ArticleTargeted oncology2026

Beyond Contraindication-Based Selection: The Unmet Need for Predictive Biomarkers in First-Line Immunotherapy for Advanced HCC.

Alireza Tojjari et al.PubMed ↗Publisher ↗

No numbers read from the abstract.